Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
08/2001
08/16/2001WO2000055124A3 Novel compounds and compositions as protease inhibitors
08/16/2001EP1123274A1 Substituted phenyl derivatives, their preparation and use
08/16/2001EP0558677B1 Biologically active amines
08/16/2001DE10004487A1 Physically-, thermally- and/or light-curable, aqueous coating, adhesive or sealant composition, e.g. water-borne basecoat, contains a polyalkylene ether-terminated, aromatic bis-urethane-urea as rheology additive
08/15/2001CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
08/15/2001CN1069633C Iodinated X-ray contrast media
08/09/2001WO2001057105A1 Aqueous composition that can be hardened physically, thermally or thermally and with actinic radiation and the derivatives and production thereof
08/09/2001WO2001056988A1 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
08/09/2001WO2001056978A1 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof
08/09/2001WO2001056975A1 Substituted imide derivatives
08/09/2001WO2000071506A3 Naphthalene ureas as glucose uptake enhancers
08/09/2001US20010011515 Mixture of an urea and phenolic compound
08/09/2001DE10004498A1 New diethyloctandiol dicarbamate and diethyloctandiol diallophanate positional isomers are used for vehicle and electronic parts
08/09/2001CA2399085A1 Substituted imide derivatives
08/09/2001CA2398648A1 Diethyloctandioldicarbamates and diethyloctandioldiallophanates, method for the production and use thereof
08/08/2001CN1307581A Method for producing anellated triazoles and new anellated trizoles and their use
08/07/2001US6271261 Chemokine mediated diseases, binding interleukins or beta-receptors and administering to mammals
08/02/2001WO2001055146A1 FACTOR Xa INHIBITORS WITH ARYL-AMIDINES AND DERIVATIVES, AND PRODRUGS THEREOF
08/02/2001WO2001055095A1 Functional monomers for molecular recognition and catalysis
08/02/2001WO2001055081A2 Esters of fatty acids and juvenoid alcohols, and a method of their preparation and use
08/02/2001US20010011136 Anticancer agents
08/02/2001US20010011135 Anticancer agents
08/02/2001DE10004084A1 Substituierte Imid-Derivate Substituted imide derivatives
08/01/2001CN1306512A Heterocyclic inhibitors of P38
07/2001
07/31/2001US6268507 Hydantoin derivatives
07/31/2001US6268387 Inhibitors of the enzyme 15-lipoxygenase and are inhibitors of monocyte chemotaxis.
07/31/2001US6268311 1-Amino-3-benzyluracils
07/31/2001US6268181 Culturing bacillus strains to produce a fermentation broth; collecting supernatant and isolating a factor as determined by nuclear magnetic resonance
07/26/2001WO2001053279A1 Urea compounds as inhibitors for vla-4
07/26/2001WO2001052900A2 Novel orthogonally protected amino acid chelators for biomedical applications
07/25/2001EP1117716A1 Oligomeric and high-molecular conversion products of allophanic acid esters with nucleophilic compounds and low-molecular, oligomeric and high-molecular compounds with allophanate side and/or terminal groups, and the use thereof
07/25/2001CN1305457A Novel antiestrogens, method for production thereof and their pharmaceutical application
07/24/2001US6265605 Additive in processed meat, beverages, and in other processed food stuffs; as intermediates in drugs, agricultural chemicals and pesticides, herbicides
07/24/2001US6265445 Cardiovascular disorders
07/24/2001CA2116621C Novel anticancer agents
07/19/2001WO2001051487A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
07/19/2001WO2001051456A2 Antibacterial agents
07/19/2001CA2397575A1 Antibacterial agents
07/19/2001CA2396087A1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
07/18/2001EP1116713A1 Novel color-developing compound and recording material
07/18/2001EP1115758A2 Polymerization of olefins
07/18/2001EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
07/18/2001EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY
07/18/2001EP0850221B1 Meta-guanidine, urea, thiourea or azacyclic amino benzoic acid derivatives as integrin antagonists
07/18/2001EP0721446B1 Chiral surfactants and methods for their use in chiral separations
07/18/2001CN1304400A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
07/18/2001CN1068583C N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
07/10/2001US6258850 3-aryl-2-hydroxypropionic acid derivative (I)
07/10/2001US6258822 Urokinase inhibitors
07/10/2001CA2217425C Improved urea synthesis process and apparatus therefor
07/05/2001WO2001047875A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/05/2001US20010007012 Reacting a compound having urethane functionality with a compound having isocyanate functionality in the presence of a metal catalyst and a tertiary amine
07/05/2001CA2395716A1 Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
07/03/2001US6255432 Urea-amide or urethane-amide material obtained by reacting mono- or diisocyanate with functional amide formed from hydroxy functional primary or secondary amine or diprimary diamine and mono-, di- or hydroxyfunctional carboxylic acid
07/03/2001US6255351 Treatment of bone disorders
07/03/2001US6255326 Antiinflammatory agent; autoimmune diseases
07/03/2001CA2208022C Process and plant for the production of urea with high conversion yield and low energy consumption
06/2001
06/28/2001WO2001046124A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
06/28/2001WO2001045678A2 Medicament, a method for its production and the use thereof
06/28/2001WO2000066104A3 Ace-2 inhibiting compounds and methods of use thereof
06/28/2001WO1999063937A9 Multivalent macrolide antibiotics
06/28/2001US20010005738 Building blocks containing isocyanate groups and their use for functionalizing or modifying compounds or surfaces
06/28/2001DE19962272A1 Isocyanatgruppen aufweisende Bausteine sowie ihre Verwendung zur Funktionalisierung oder Modifizierung von Verbindungen oder Oberflächen Containing isocyanate components and their use for functionalizing or modifying compounds or surfaces
06/27/2001EP1110946A2 Subunits containing isocyanate groups and their use for functionalising or modifying compounds or surfaces
06/27/2001EP0718281B1 Cyclohexanediurea derivative and process for producing the same
06/27/2001CN1067678C Alkyl heterocyclic compound and preparation method thereof, and medicinal composition containing that kind of compound
06/26/2001US6252104 3,6-disubstituted-2-oxynaphthalene derivatives; raw materials for synthesis of such materials as dyes, pigments, photosensitive materials
06/26/2001US6252103 Preparation on an O-alkylisourea
06/26/2001US6252083 Fungicides, insecticides, nematocides
06/26/2001US6251944 (vitronectin receptor) integrin antagonist, useful for treating angiogenesis, tumor growth, tumor metastasis, osteoporosis and humoral hypercalcemia of malignancy
06/21/2001WO2001044223A1 Inhibitors of interleukin 5 gene expression
06/21/2001WO2001044216A1 Trans olefinic glucokinase activators
06/21/2001CA2393027A1 Inhibitors of interleukin 5 gene expression
06/20/2001EP1108717A2 C7 taxane derivatives and pharmaceutical compositions containing them
06/20/2001EP1107949A2 Process for preparing certain phenyl urea compounds
06/20/2001EP1107948A1 An improved synthesis of 3-hydroxy-4-amino-benzonitrile
06/20/2001EP1107944A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
06/20/2001EP0929515B1 Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
06/20/2001CN1300277A Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
06/19/2001US6248787 Reducing cachexia
06/14/2001WO2001042192A2 Vla-4 integrin antagonists
06/14/2001CA2388686A1 Vla-4 integrin antagonists
06/13/2001EP1105372A1 Methoximinophenylacetic acid amides
06/13/2001CN1067050C Method for prodn. of 3-alkoxy-2-substituted phenmethyl acid or ester thereof
06/07/2001WO2001040188A1 Curcumin analogues for treating cancer
06/07/2001WO2001030749B1 Novel compounds
06/07/2001WO2000075106A3 Matrix metalloproteinase inhibitors and method of using same
06/07/2001WO1999063940A3 INHIBITORS OF H+K+-ATPase
06/07/2001CA2393440A1 Curcumin analogs with anti-tumor and anti-angiogenic properties
05/2001
05/31/2001WO2001038322A1 Inhibitors of histone deacetylase
05/30/2001EP1102742A2 Compounds and compositions for delivering active agents
05/30/2001CN1066437C Improved urea synthesis process and apparatus
05/29/2001US6239074 Substituted 3-phenyluracils
05/25/2001WO2001036403A1 Urea derivatives as anti-inflammatory agents
05/25/2001WO2001036381A1 Hydrazone compounds and pesticides
05/25/2001WO2001036376A1 Novel phenylalanine derivatives
05/25/2001WO2001036375A1 Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
05/23/2001EP1100770A2 Monomers and network polymers obtained therefrom
05/23/2001EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases
05/23/2001EP1100483A2 Glucocorticoid-selective anti-inflammatory agents
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 99